1. Home
  2. GEVO vs CTKB Comparison

GEVO vs CTKB Comparison

Compare GEVO & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEVO
  • CTKB
  • Stock Information
  • Founded
  • GEVO 2005
  • CTKB 1990
  • Country
  • GEVO United States
  • CTKB United States
  • Employees
  • GEVO N/A
  • CTKB N/A
  • Industry
  • GEVO Major Chemicals
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GEVO Industrials
  • CTKB Health Care
  • Exchange
  • GEVO Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • GEVO 498.2M
  • CTKB 433.8M
  • IPO Year
  • GEVO 2011
  • CTKB 2021
  • Fundamental
  • Price
  • GEVO $2.21
  • CTKB $3.84
  • Analyst Decision
  • GEVO Buy
  • CTKB Hold
  • Analyst Count
  • GEVO 2
  • CTKB 4
  • Target Price
  • GEVO $8.13
  • CTKB $6.00
  • AVG Volume (30 Days)
  • GEVO 6.9M
  • CTKB 858.8K
  • Earning Date
  • GEVO 11-06-2025
  • CTKB 11-04-2025
  • Dividend Yield
  • GEVO N/A
  • CTKB N/A
  • EPS Growth
  • GEVO N/A
  • CTKB N/A
  • EPS
  • GEVO N/A
  • CTKB N/A
  • Revenue
  • GEVO $80,187,000.00
  • CTKB $196,035,000.00
  • Revenue This Year
  • GEVO $909.99
  • CTKB N/A
  • Revenue Next Year
  • GEVO $22.37
  • CTKB $7.25
  • P/E Ratio
  • GEVO N/A
  • CTKB N/A
  • Revenue Growth
  • GEVO 341.75
  • CTKB N/A
  • 52 Week Low
  • GEVO $0.92
  • CTKB $2.37
  • 52 Week High
  • GEVO $3.39
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • GEVO 64.72
  • CTKB 51.31
  • Support Level
  • GEVO $2.14
  • CTKB $3.71
  • Resistance Level
  • GEVO $2.37
  • CTKB $4.04
  • Average True Range (ATR)
  • GEVO 0.13
  • CTKB 0.20
  • MACD
  • GEVO 0.01
  • CTKB 0.03
  • Stochastic Oscillator
  • GEVO 65.56
  • CTKB 73.48

About GEVO Gevo Inc.

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: